ETC
CRBU icon

Exchange Traded Concepts’s Caribou Biosciences CRBU Stock Holding History

Exchange Traded Concepts’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-124,889
Closed -$114K – 1428
2025
Q1 		$114K Buy
124,889
+42,395
+51% +$55.1K ﹤0.01% 1111
2024
Q4 		$131K Hold
82,494
– – ﹤0.01% 1093
2024
Q3 		$162K Buy
82,494
+41,948
+103% +$85.9K ﹤0.01% 1032
2024
Q2 		$66.5K Sell
40,546
-12,614
-24% -$40.3K ﹤0.01% 969
2024
Q1 		$273K Buy
53,160
+29,236
+122% +$180K 0.01% 841
2023
Q4 		$137K Buy
23,924
+6,066
+34% +$30K ﹤0.01% 842
2023
Q3 		$85.4K Sell
17,858
-11,210
-39% -$69.5K ﹤0.01% 950
2023
Q2 		$124K Buy
+29,068
New +$131K ﹤0.01% 902

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exchange Traded Concepts's CRBU Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 124,889 shares — an estimated $114K sold.

Exchange Traded Concepts first reported a position in CRBU in Q2 2023 and held it in 8 quarters. The position peaked at $273K in Q1 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 124,889 Caribou Biosciences shares in Q2 2025, an estimated $114K.
  • Exchange Traded Concepts first reported a position in Caribou Biosciences in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Caribou Biosciences position peaked at $273K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.